Home › Funds › Sofinnova Investments, Inc. › IRON
Sofinnova Investments, Inc. position in IRON
DISC MEDICINE INC · Health Care
Sofinnova Investments, Inc. reported holding 146,239 shares of IRON (DISC MEDICINE INC) in its Q2 2026 13F filing — a position valued at US$10.7M, representing 0.57% of its reported portfolio and ranking #39 among its reported holdings. Sofinnova Investments, Inc. has disclosed IRON holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Sofinnova Investments, Inc.'s IRON position evolved
Sofinnova Investments, Inc. first disclosed a stake in IRON in Q1 2024 at 6,173 shares (US$384K). The position peaked in Q2 2026 at 146,239 shares, worth US$10.7M. Across 10 filings, Sofinnova Investments, Inc. increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 146,239 shares valued at US$10.7M — an increase of 67,919 shares quarter over quarter.. Notable position changes include a 374% increase in Q2 2024 (shares rose 9% over the following quarter), a 719% increase in Q4 2025 (shares fell 19% over the following quarter), a 87% increase in Q2 2026 (shares fell 11% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 6.17K | $384.33K | New |
| Q2 2024 | 29.26K | $1.32M | Add |
| Q3 2024 | 41.35K | $2.03M | Add |
| Q4 2024 | 22.75K | $1.44M | Reduce |
| Q1 2025 | 7.49K | $371.56K | Reduce |
| Q2 2025 | 7.31K | $387.24K | Reduce |
| Q3 2025 | 13.55K | $895.58K | Add |
| Q4 2025 | 111.01K | $8.82M | Add |
| Q1 2026 | 78.32K | $5.01M | Reduce |
| Q2 2026 | 146.24K | $10.70M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IRON and 13F data
IRON (DISC MEDICINE INC) is a Health Care company. 42 other funds we track also report a position in IRON — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$179.2M), Vestal Point Capital, LP (US$113.4M), Atlas Venture Life Science Advisors, LLC (US$110.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IRON
- RA CAPITAL MANAGEMENT, L.P. 2.45M sh · $179.21M · Q2 2026
- Vestal Point Capital, LP 1.55M sh · $113.37M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 1.51M sh · $110.72M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.35M sh · $99.09M · Q2 2026
- TCG Crossover Management, LLC 1.34M sh · $98.14M · Q2 2026
- BVF INC/IL 1.15M sh · $84.38M · Q2 2026
- Siren, L.L.C. 888.40K sh · $64.98M · Q2 2026
- Logos Global Management LP 875.00K sh · $64.00M · Q2 2026
- Opaleye Management Inc. 855.00K sh · $62.53M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 657.00K sh · $48.05M · Q2 2026
- Bellevue Group AG 560.00K sh · $40.96M · Q2 2026
- Saturn V Capital Management LP 524.73K sh · $38.38M · Q2 2026
More on Sofinnova Investments, Inc.
FAQ
How long has Sofinnova Investments, Inc. held IRON?
Sofinnova Investments, Inc. has disclosed IRON holdings in 10 of the last 10 reported quarters, going back to Q1 2024.
What is Sofinnova Investments, Inc.'s current position in IRON?
As of Q2 2026, Sofinnova Investments, Inc. holds 146.24K shares of IRON (DISC MEDICINE INC), valued at $10.70M, representing 0.57% of its reported portfolio and ranking #39.
Has Sofinnova Investments, Inc. been buying or selling IRON?
In the latest 13F filing (Q2 2026), Sofinnova Investments, Inc. increased its position in IRON. The position peaked in Q2 2026 at 146.24K shares.
Which other funds hold IRON?
Other major institutional holders of IRON include RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, Atlas Venture Life Science Advisors, LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.